PepGen nabs $112.5m
PepGen Inc, a developer of oligonucleotide therapies for neuromuscular and neurologic diseases, has raised $112.5 million in financing.
PepGen Inc, a developer of oligonucleotide therapies for neuromuscular and neurologic diseases, has raised $112.5 million in financing.
Copyright PEI Media
Not for publication, email or dissemination